The in vitro release of endogenous m-tyramine, p-tyramine and dopamine from rat striatum
- PMID: 7121718
- DOI: 10.1007/BF00965523
The in vitro release of endogenous m-tyramine, p-tyramine and dopamine from rat striatum
Abstract
Administration of phenelzine (100 mg/kg. i.p., 18 hr) increased rat striatal concentrations of pTA, mTA and DA by 30, 6.7 and 1.5 fold, respectively. Lesions of the medial forebrain bundle prevented these increases, permitting the conclusion that the phenelzine-induced amine increases were localized in the synaptic terminals. The release of endogenous pTA, mTA and DA from striatal slices obtained from phenelzine-treated rats was investigated, 50 mM KC1l elicited releases of pTA, mTA and DA which were significantly greater than their respective basal releases. These K+-stimulated releases were antagonized significantly by 15 mM MgCl2, suggesting that they are calcium-dependent in nature. We have concluded, therefore, that mTA and pTA, as well as DA, are released from striatal nerve terminals in vivo. The total amounts of mTA and DA, but not pTA, released in the release experiments were greater than those found in the nonincubated tissue. It appears, therefore, that the biosynthesis of mTA and DA was stimulated during the incubation of the striatal slices.
Similar articles
-
Potentiation of the biochemical effects of beta-phenylethylhydrazine by deuterium substitution.Biochem Pharmacol. 1983 May 1;32(9):1519-22. doi: 10.1016/0006-2952(83)90475-6. Biochem Pharmacol. 1983. PMID: 6860370
-
Release of some endogenous trace amines from rat striatal slices in the presence and absence of a monoamine oxidase inhibitor.Life Sci. 1989;44(17):1149-56. doi: 10.1016/0024-3205(89)90309-3. Life Sci. 1989. PMID: 2716465
-
A comparison of the effects of methylphenidate and amphetamine on the simultaneous release of radiolabelled dopamine and p- or m-tyramine from rat striatal slices.Eur J Pharmacol. 1980 Nov 7;68(1):33-40. doi: 10.1016/0014-2999(80)90057-6. Eur J Pharmacol. 1980. PMID: 7449832
-
The behavioural effects of phenelzine and phenylethylamine may be due to amine release.Brain Res Bull. 1984 Jan;12(1):23-8. doi: 10.1016/0361-9230(84)90210-7. Brain Res Bull. 1984. PMID: 6713212
-
Administration of supplemental L-tyrosine with phenelzine: a clinical literature review.Clin Pharmacol. 2014 Jul 22;6:107-10. doi: 10.2147/CPAA.S67271. eCollection 2014. Clin Pharmacol. 2014. Retraction in: Clin Pharmacol. 2021 Mar 03;13:39. doi: 10.2147/CPAA.S308255. PMID: 25092999 Free PMC article. Retracted. Review.
Cited by
-
Overlap and Specificity in the Substrate Spectra of Human Monoamine Transporters and Organic Cation Transporters 1, 2, and 3.Int J Mol Sci. 2021 Nov 26;22(23):12816. doi: 10.3390/ijms222312816. Int J Mol Sci. 2021. PMID: 34884618 Free PMC article.
-
Release of endogenous dopamine, 3,4-dihydroxyphenylacetic acid, and amino acid transmitters from rat striatal slices.Neurochem Res. 1985 Apr;10(4):515-27. doi: 10.1007/BF00964655. Neurochem Res. 1985. PMID: 2860579
-
Cerebral decarboxylation of meta- and para-tyrosine.Experientia. 1983 Feb 15;39(2):130-4. doi: 10.1007/BF01958860. Experientia. 1983. PMID: 6832285
-
The amine oxidase inhibitor phenelzine limits lipogenesis in adipocytes without inhibiting insulin action on glucose uptake.J Neural Transm (Vienna). 2013 Jun;120(6):997-1003. doi: 10.1007/s00702-012-0951-3. Epub 2012 Dec 16. J Neural Transm (Vienna). 2013. PMID: 23242743